Skip to main content
Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · IEX Real-Time Price · USD
1.350
0.00 (0.00%)
At close: Jul 2, 2024, 3:59 PM
1.320
-0.030 (-2.22%)
After-hours: Jul 2, 2024, 7:49 PM EDT

Milestone Pharmaceuticals Revenue

In the year 2023, Milestone Pharmaceuticals had annual revenue of $1.00M, a decrease of -80.00%.

Revenue (ttm)
$1.00M
Revenue Growth
-80.00%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
47
Market Cap
71.90M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.00M-4.00M-80.00%
Dec 31, 20225.00M-10.00M-66.67%
Dec 31, 202115.00M--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Eagle Pharmaceuticals 257.55M
CASI Pharmaceuticals 33.88M
Marinus Pharmaceuticals 28.29M
Celularity 14.79M
Serina Therapeutics 3.15M
Revenue Rankings

MIST News

More News